Ocular complication in congenital erythropoietic porphyria

Ophthalmologica

Volumn 210, Issue 3, 1996, Pages 183-185

  Tanigawa, Ken ^a   Takamura, Noboru ^a   Nakata, Keisuke ^b   Nagataki, Shigenobu ^b   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congenital erythropoietic porphyria; Scleral involvement

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; FEMALE; HUMAN; MALE; SCLERITIS;

EID: 0029886351     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000310704     Document Type: Article

References (19)

1. Kappas A, Sassas S, Anderson KE: The metabolic basis of inherited disease; in Serivner JR (ed): The Porphyrias. New York. McGraw Hill, 1989, pp 1305-1365.
2. Iihutani LK, Sood SK. Das PK. Dcsphandc SG, Mulay DN. Kandhari KC: Congenital erythropoietic porphyria: An autopsy report. Arch Dermatol 1974:110:427-431.
3. Nordmann Y, Daybach JC: Congenital erythropoietic porphyria. Semin Liver Dis 1982:2: 154-163.
4. Dahle JS, Eriksen L, Romslo I, Thune P: Congenital erythropoietic porphyria: A case report with discussion of different porphyrin excretion patterns. Photodermatology 1984:1:187-190.
5. Poh-Fitzpatrick MB: The erythropoietic porphyrias. Dermatol Clin 1986;4:291-295.
6. Piomelli S, Poh-Fitzpatrick MB, Seaman C, Skolnick LM, Berdon WE: Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. N Engl J Med 1986: 314:1029-1031.
7. Gray CH, Neuberger A: Effect of splenectomy in a case of congenital erythropoietic porphyria. Lancet 1952;1:851-854.
8. Pimstone NR, Gandhi SN, Mukerji SK: Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. N Engl J Med 1987: 316:390.
9. Rank JM, Straka JG, Weimer MK, Bossenmaeier I, Taddeini L, Bloomer JR: Hcmatin therapy in late onset of congenital erythropoietic porphyria. BrJ Haematol 1990:75:617-622.
10. Kauffman L, Evans DJ, Stevens RF, Weinkove C: Bonc-marrow transplantation for congenital erythropoietic porphyria. Lancet 1991;337: 1510-1511.
11. Tanigawa K, Namba H, Ohtsuru A, Shima M, Nakata K, Kondo M, Nagataki S, Yamashita S: Plasmasorbent therapy with activated charcoal column for congenital erythropoietic porphyria. Dermatology 1994:188:329-330.
12. Chumbley LC: Seleral involvement in symptomatic porphyria. Am J Ophthalmol 1977;84: 729-733.
13. Oguz F, Sidal M, Bayram C, Sansoy N, Hekim N: Ocular involvement in two symptomatic congenital erythropoietic porphyria. Eur J Pc-diatr 1993:152:671-673.
14. Tsai SF, Bishop DF, Desnick RJ: Human uroporphyrinogen III synthase; Molecular cloning, nucleotide sequence, and expression of a full length cDNA. Proc Natl Acad Sci USA 1988; 85:7049-7053.
15. Deybach JC, de Verneuil H, Boulechfar S, Grandchamp B, Nordmann Y: Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Gunther's disease). Blood 1990;75:1763-1765.
16. Nordmann Y, Deybach JC, de Verneuil H, Boulechfar S. Grandchamp B: Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Gunther’s disease). Curr Probl Dermatol 1991:20:148-153.
17. Boulechfar S, Silva V, Deybach JC, Nordmann Y, Grandchamp B, de Verneuil H: Heterogeneity of mutations in the uroporphyrinogen 111 synthase gene in congenital erythropoietic porphyria. Hum Genet 1992;88:320-324.
18. Warner CA, Yoo HW, Roberts AG, Desnick RJ: Congenital erythropoietic porphyria: Identification and expression of cxonic mutations in the uroporphyrinogen 111 synthase gene. J Clin Invest 1992;89:693-700.
19. Nordmann Y, de Verneuil H, Deybach JC, Del-fau MH. Grandchamp B: Molecular genetics of porphyrias. Ann Med 1990;22:387-391.